XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated other comprehensive (loss) income
Accumulated other comprehensive (loss) income, Foreign currency translation
Accumulated other comprehensive (loss) income, Defined benefit pension plans
Treasury stock
Balance at the beginning of the year at Dec. 31, 2023   $ 2,709 $ 1,168,694 $ 9,940,343   $ (298,835) $ (186,107) $ (1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   8            
Issuance of common stock under employee stock plans and other     25,069         5,843
Share-based compensation expense     34,907          
Net income $ 988,867     988,867        
Cash dividends paid       (194,068)        
Other       (2)        
Translation adjustments           40,231    
Change in long-term intercompany notes           (1,942)    
Net investment hedge instruments (loss) gain , net of tax of $(2,022) and $9,595 for the quarter ended September 30, 2025 and 2024 and $23,934 and $4,678 for the nine months ended September 30, 2025 and 2024, respectively           (14,366)    
Amortization of net actuarial loss and other, net of tax of $(296)and $(365) for the quarter ended September 30, 2025 and 2024 and $(888) and $(1,095) for the nine months ended September 30, 2025 and 2024, respectively             3,480  
Purchase of treasury stock               (67,995)
Balance at the end of the year at Sep. 30, 2024 9,550,223 2,717 1,228,670 10,735,140 $ (457,539) (274,912) (182,627) (1,958,765)
Balance at the beginning of the year at Jun. 30, 2024   2,716 1,210,414 10,459,556   (338,606) (183,787) (1,897,889)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   1            
Issuance of common stock under employee stock plans and other     5,513         (476)
Share-based compensation expense     12,743          
Net income 340,241     340,241        
Cash dividends paid       (64,657)        
Other       0        
Translation adjustments           91,052    
Change in long-term intercompany notes           2,106    
Net investment hedge instruments (loss) gain , net of tax of $(2,022) and $9,595 for the quarter ended September 30, 2025 and 2024 and $23,934 and $4,678 for the nine months ended September 30, 2025 and 2024, respectively           (29,464)    
Amortization of net actuarial loss and other, net of tax of $(296)and $(365) for the quarter ended September 30, 2025 and 2024 and $(888) and $(1,095) for the nine months ended September 30, 2025 and 2024, respectively             1,160  
Purchase of treasury stock               (60,400)
Balance at the end of the year at Sep. 30, 2024 9,550,223 2,717 1,228,670 10,735,140 (457,539) (274,912) (182,627) (1,958,765)
Balance at the beginning of the year at Dec. 31, 2024 9,655,304 2,720 1,264,670 11,057,684   (392,133) (163,606) (2,114,031)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   3            
Issuance of common stock under employee stock plans and other     (8,443)         12,619
Share-based compensation expense     35,229          
Net income 1,081,541     1,081,541        
Cash dividends paid       (214,370)        
Other       0        
Translation adjustments           201,697    
Change in long-term intercompany notes           (5,699)    
Net investment hedge instruments (loss) gain , net of tax of $(2,022) and $9,595 for the quarter ended September 30, 2025 and 2024 and $23,934 and $4,678 for the nine months ended September 30, 2025 and 2024, respectively           (76,253)    
Amortization of net actuarial loss and other, net of tax of $(296)and $(365) for the quarter ended September 30, 2025 and 2024 and $(888) and $(1,095) for the nine months ended September 30, 2025 and 2024, respectively             2,826  
Purchase of treasury stock               (157,578)
Balance at the end of the year at Sep. 30, 2025 10,526,876 2,723 1,291,456 11,924,855 (433,168) (272,388) (160,780) (2,258,990)
Balance at the beginning of the year at Jun. 30, 2025   2,723 1,275,795 11,624,849   (244,679) (161,722) (2,108,294)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   0            
Issuance of common stock under employee stock plans and other     2,745         (195)
Share-based compensation expense     12,916          
Net income 371,416     371,416        
Cash dividends paid       (71,410)        
Other       0        
Translation adjustments           (34,294)    
Change in long-term intercompany notes           144    
Net investment hedge instruments (loss) gain , net of tax of $(2,022) and $9,595 for the quarter ended September 30, 2025 and 2024 and $23,934 and $4,678 for the nine months ended September 30, 2025 and 2024, respectively           6,441    
Amortization of net actuarial loss and other, net of tax of $(296)and $(365) for the quarter ended September 30, 2025 and 2024 and $(888) and $(1,095) for the nine months ended September 30, 2025 and 2024, respectively             942  
Purchase of treasury stock               (150,501)
Balance at the end of the year at Sep. 30, 2025 $ 10,526,876 $ 2,723 $ 1,291,456 $ 11,924,855 $ (433,168) $ (272,388) $ (160,780) $ (2,258,990)